{"slideshow_credits": null, "snippet": "AbbVie agreed on Friday to buy the Irish drug maker Shire for around $54 billion. | Alibaba has pushed its I.P.O. to September. | Growth in wealth management bolstered Morgan Stanley\u2019s second-quarter profit. | New York State\u2019s top financial...", "abstract": "AbbVie agreed on Friday to buy the Irish drug maker Shire for around $54 billion. | Alibaba has pushed its I.P.O. to September. | Growth in wealth management bolstered Morgan Stanley\u2019s second-quarter profit. | New York State\u2019s top financial regulator has proposed regulations for virtual currency companies.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Sydney", "role": "reported", "lastname": "EMBER", "rank": 1, "organization": ""}], "original": "By SYDNEY EMBER"}, "web_url": "http://dealbook.nytimes.com/2014/07/18/morning-agenda-abbvie-wins-deal-for-shire/", "lead_paragraph": null, "headline": {"main": "Morning Agenda: AbbVie Wins Deal for Shire", "kicker": "DealBook"}, "_id": "53c9044538f0d80b5141b958", "word_count": "1869", "multimedia": [], "pub_date": "2014-07-18T07:24:31Z", "source": "The New York Times", "news_desk": "Business", "keywords": [], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}